Dr. Harvey graduated in medicine from the University of Melbourne and, after working in Papua and New Guinea, specialised in medical microbiology and infectious diseases. An interest in antibiotic resistance led to a study of antibiotic prescribing and then the forces at work on the pen that writes the ‘script. This eventually resulted in a move from The Royal Melbourne Hospital to the School of Public Health at La Trobe University where he focused on medicinal drug policy.
Dr. Harvey was a member of the expert group that drafted the World Health Organization “Ethical Criteria for Medicinal Drug Promotion”. He helped set up Therapeutic Guidelines Pty Ltd and has been, at various times author, Chair of Antibiotic Writing Group and Board Member. He remains a member of the company.
Dr Harvey was also a member of the Commonwealth Pharmaceutical Health and Rational use of Medicines (PHARM) Committee that formulated the Quality Use of Medicines (QUM) pillar of Australian medicines policy.
Dr. Harvey has worked on these issues in SE Asia under a variety of auspices: WHO, AusAID and especially Consumers International (Health Action International Asia Pacific). He was the Australian project director of a $4.0 million, 4 year AusAID program of assistance to the Philippines National Drug Policy and has assisted HAIAP in Malaysia, Indonesia, Sri Lanka, India, Bangladesh, Pakistan, Laos, Vietnam, China, Singapore, Hong Kong and the Philippines. He has also worked as a consultant for the Australian Health Insurance Commission (and USAID) on medicinal drug policy reform in Croatia and Jordan.
Dr. Harvey’s interests in information technology and the optimisation of medicinal drug use converged in the area of E-Health, including health informatics policy and computerised decision support, especially electronic medication management.
His interest in ethical promotion has led to involvement in a number of Australian government reviews on the regulation of therapeutic goods promotion and complementary medicines.
Dr. Harvey has been awarded life membership of Choice (the Australian Consumers’ Association) for services to the consumer movement and life membership of the Australian Skeptics for recognition of his relentless campaigning against shonky medical products and claims.
In early 2014 Dr Harvey resigned from La Trobe University because of their partnership with Swisse Wellness Pty Ltd.
He was then offered, and accepted, a position of Adjunct Associate Professor, School of Public Health and Preventive Medicine, Monash University. In 2017, this unpaid position was converted to a paid sessional (one half-day per week) Associate Professor appointment.
In 2016, Dr Harvey was awarded the Australian and New Zealand Association Advancement of Science (ANZAAS) Medal for the, “the teaching of science throughout Australia and New Zealand and contributions to science which lie beyond normal professional activities.”
In 2017, he was made a Member (AM) in the General Division of the Order of Australia, “for significant service to community health and the pharmaceutical industry through roles in developing guidelines for the ethical use of antibiotics.
In 2019, Dr Harvey became President of Friends of Science in Medicine, taking over the role from Emeritus Professor John Dwyer.
In 2020, Dr Harvey resigned as the Choice representative of the Therapeutic Goods Advertising Consultative Committee (TGACC) because of the TGA’s longstanding, ineffectual and token enforcement of complementary medicines violations.
In 2021, Dr Harvey’s appointment at Monash University was not renewed, in part (like many others) due to the financial crisis caused by COVID-19 and lack of government support for universities. In addition, a new Head of School had decided that his area of expertise no longer fitted with the direction of the School of Public Health and Preventative Medicine.
Download Dr Harvey’s Curriculum Vitaeby